Skip to main navigation Skip to search Skip to main content

Role of the endocannabinoid system in hepatic lipogenesis

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Endocannabinoids are endogenous lipid mediators recognized by the cannabinoid-1 and 2 (CB1 and CB2, respectively) receptors that mediate the effects of marijuana. The endocannabinoid system, consisting of endocannabinoids (eCBs), their receptors, and the enzymes involved in their biosynthesis and degradation, is present in many tissues including the liver. The present chapter reviews accumulating evidence that the eCB system is involved in the regulation of de novo hepatic lipogenesis.

Original languageEnglish
Title of host publicationHepatic De Novo Lipogenesis and Regulation of Metabolism
Pages131-142
Number of pages12
ISBN (Electronic)9783319250656
DOIs
StatePublished - 1 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CB receptor
  • Diet-induced obesity
  • Endocannabinoids
  • Fatty liver
  • Hepatic lipogenesis
  • Monounsaturated fatty acids

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology
  • General Medicine

Fingerprint

Dive into the research topics of 'Role of the endocannabinoid system in hepatic lipogenesis'. Together they form a unique fingerprint.

Cite this